methylprednisolone and Lupus Nephritis

methylprednisolone has been researched along with Lupus Nephritis in 169 studies

Research

Studies (169)

Timeframe	Studies, this research(%)	All Research%
pre-1990	10 (5.92)	18.7374
1990's	50 (29.59)	18.2507
2000's	52 (30.77)	29.6817
2010's	46 (27.22)	24.3611
2020's	11 (6.51)	2.80

Authors

Authors	Studies
Aggarwal, A; Chatterjee, R; Kharbanda, R; Marak, RSK; Mehndiratta, A	1
Duarte-García, A; Williamson, KA; Yang, JX	1
Chien, JW; Chiu, PF; Chiu, YM; Hsiao, KH; Lin, CY; Su, TC; Tsai, YG	1
Berg, SIT; Braunstein, M; Knapp, J; Shirriff, C	1
Deng, XH; Huang, F; Li, KP; Liao, SM; Liu, XF; Yang, JS; Zhang, JL; Zhao, YR; Zheng, X; Zhu, J	1
El-Owaidy, R; El-Zohiery, A; Tomoum, H	1
Aratani, S; Itagaki, F; Kashiwagi, T; Kawasaki, S; Mugishima, K; Shimizu, A; Terada, K; Tsuruoka, S; Yamada, T	1
Prurapark, P; Rianthavorn, P	1
Chandra, T; Tilstra, JS	1
Al-Adhoubi, NK; Bystrom, J	1
Fujinaga, S; Furuichi, M; Imai, K; Kawano, Y; Nakamura, K; Ohnishi, T; Sato, S; Suganuma, E; Uejima, Y	1
Adamichou, C; Aydin, S; Demoulin, N; Gomez, A; Houssiau, FA; Parodis, I; Tamirou, F; Weinmann-Menke, J	1
Blanco, P; Bueno, L; Dominguez-Cainzos, J; Dueña-Bartolome, L; Duffau, P; Dunder, S; Gomez-Carballo, C; Lazaro, E; Richez, C; Rodrigo-Manjon, A; Ruiz-Irastorza, G; Varona, J	1
Deng, D; Guo, Y; Lim, TO; Zhang, P	1
Blanco, P; Couzi, L; Iza, A; Lazaro, E; Porta, S; Richez, C; Ruiz-Irastorza, G; Saenz, R; Saint-Pastou Terrier, C; Ugarte, A	1
Hong, H; Li, X; Ma, Z; Wang, M; Yang, R	1
Fujikawa, K; Fukui, S; Horai, Y; Ichinose, K; Igawa, T; Iwamoto, N; Kawakami, A; Kawashiri, SY; Kitamura, M; Koga, T; Matsuoka, N; Nakamura, H; Nishino, T; Nonaka, F; Origuchi, T; Sato, S; Shimizu, T; Tamai, M; Tsuboi, M; Umeda, M	1
de la Hoz, L; Martinez, GA; Martinez-Bayona, A; Musso, CG; Tolosa, RG; Torres, HG	1
Bortolotti, D; Bortoluzzi, A; Botto, M; Cairns, TD; Cook, TH; Doyle, AF; Foschi, V; Govoni, M; Lightstone, L; Padovan, M; Pickering, MC; Rinaldi, R; Rizzo, R; Stephens, L; Stratigou, V; Trivedi, P	1
Aslam, L; D'Cruz, DP; Davies, RJ; Jordan, NP; Lewis, MJ; Sangle, SR; Wedgwood, R	1
Ashby, D; Cairns, TD; Condon, MB; Cook, HT; Griffith, M; Levy, JB; Lightstone, L; Pepper, RJ	1
Banfi, G; Gallelli, B; Messa, P; Moroni, G; Ponticelli, C; Quaglini, S	1
Al Malki, N; Demerdash, TM; Hussein, MM; Mooij, JM	1
Danza, A; Delgado, S; Garcia, M; Khamashta, M; Perales, I; Ruiz-Irastorza, G; Villar, I	1
Lee, CY; Lin, CY; Lin, TY; Tsai, YG	1
Imagawa, T; Kikuchi, M; Kizawa, T; Miyamae, T; Mori, M; Nagahama, K; Nakamura, T; Nozawa, T; Okudela, K; Tsutsumi, H; Yokota, S	1
Bao, H; Chen, J; Chen, N; Fu, P; Gu, Y; He, Y; Hu, W; Li, Y; Lin, H; Liu, F; Liu, Z; Miao, L; Ni, Z; Shi, W; Xing, C; Zeng, C; Zhang, H; Zhou, M	1
Christenson, ES; Hsu, S; Ligon, C	1
Chen, X; Gao, Y; Li, M; Qiu, Q; Wang, Y; Wei, R; Zhang, L; Zhang, X	1
Chan, TM; Chau, MK; Yung, S; Zhang, Q	1
Li, J; Lin, X; Pinhu, L; Qin, Y; Sooranna, SR; Yang, F; You, Y	1
Goyal, A; Gupta, KL; Gupta, PK; Jaryal, A; Jha, V; Kohli, HS; Kumar, V; Ramachandran, R; Rathi, M; Sakhuja, V; Sharma, A	1
Aragon, E; Chan, YH; Lau, YW; Loh, HL; Ng, KH; Resontoc, LP; Tan, PH; Yap, HK	1
Hou, J; Hu, W; Huang, L; Huang, X; Liu, Z; Zhang, H; Zhou, M	1
Babu, BG; Basu, B; Roy, B	1
Baysun, S; Bek, K; Bülbül, M; Delibaş, A; Demircin, G; Erdoğan, O; Oksal, A; Oner, A	1
Chen, W; Chou, C; Lee, H; Su, K; Tsai, C	1
Bohmová, J; Jedlickova, H; Sirotkova, A	1
Asaka, M; Atsumi, H; Chikazawa, Y; Fujimoto, K; Imamura, H; Imura, J; Kimura, S; Nakagawa, S; Okuyama, H; Tomosugi, N; Yamaya, H; Yokoyama, H	1
Kwok, CL; Leung, YY; Li, EK; Li, M; Li, TK; Szeto, CC; Tam, LS; Wong, KC; Zhu, TY	1
Araújo, F; Canto, AP; Gehlen, M; Haider, O; Skare, TL	1
Akimoto, T; Inoue, M; Kanashiki, E; Kato, M; Kusano, E; Meguro, D; Muto, S; Nakazawa, E; Tozawa, R; Yumura, W	1
Ando, T; Hattori, S; Honda, M; Ikeda, M; Sasaki, S; Tanaka, Y; Yoshikawa, N	1
Andrianarisoa, AC; Andrianasolo, R; Rakotoarivelo, R; Rakotomizao, JR; Rakotoson, JL; Randriamanana, D	1
Fujita, T; Fuke, Y; Ikeda, K; Ito, K; Kajiwara, M; Matsumoto, K; Satomura, A; Shimizu, C	1
Botelho, C; Carreira, A; Ferrer, F; Francisco, L; Maia, P; Mendes, T	1
Dzemidzić, J; Hamzić-Mehmedbasić, A; Muslimović, A; Rakanović-Todić, M; Rasić, S; Rebić, D; Srna, A; Uncanin, S	1
Akyüz, SG; Arda, N; Bülbül, M; Caltik, A; Demircin, G; Erdogan, O	1
Afkhamizadeh, M; Hashemzadeh, K; Pezeshki Rad, M; Sahebari, M	1
Brugos, B; Dul, C; Gubisch, W; Kiss, E; Sipka, S; Szegedi, G; Zeher, M	1
Okuyama, H; Yokoyama, H	1
Araki, H; Haitani, T; Isono, M; Kato, N; Morita, Y; Tsujimura, Y; Urasaki, K; Yasuda, M	1
Grados Cànovas, D; Ibernon Vilaró, M; López Álvarez, D; Moreno de Vega Lomo, V; Navarro Díaz, M; Romero, R; Sánchez Escuredo, A	1
Alpa, M; Baldovino, S; La Grotta, R; Menegatti, E; Modena, V; Naretto, C; Roccatello, D; Rossi, D; Sciascia, S	1
Fernández-Reyes, MJ; Heras, M; Saiz, A; Sánchez, R; Urrego, C; Zurita, P	1
Arends, S; Berden, JH; Berger, SP; Bijl, M; de Sévaux, RG; Derksen, RH; Grootscholten, C; Voskuyl, AE	1
Cherian, A; Mathew, M	1
Audia, S; Berthier, S; Bonnotte, B; Janikashvili, N; Leguy, V; Lorcerie, B; Martin, L; Samson, M	1
Hara, T; Hiromasa, T; Kagawa, H; Makino, H; Sada, KE; Takaki, A; Yamanaka, R	1
Agarwal, R; Das, A; Gundlapalli, S; Jha, V; Kohli, HS; Kumar, V; Ramachandran, R; Rathi, M; Sakhuja, V	1
Kise, T; Yoshimura, H	1
Bahi-Buisson, N; Boddaert, N; Hadj-Rabia, S; Lascelles, K; Miquel, J	1
Chiu, MC; Lai, WM; Ma, AL; Tse, NK	1
Dissaneewate, P; McNeil, E; Vachvanichsanong, P	1
Boletis, J; Gakiopoulou, H; Georgalis, A; Lionaki, S; Petra, C; Vlachopanos, G; Ziakas, P	1
Ayodele, OE; Okpechi, IG; Swanepoel, CR	1
Homel, P; Spiera, H; Spiera, RF	1
Butani, L; Makker, SP	1
Balada, E; Cortés-Hernández, J; Labrador, M; Ordi-Ros, J; Segarra, A; Tovar, JL; Vilardell-Tarres, M	1
Lindsley, CB; Samad, AS	1
Fong, KY; Thumboo, J; Vasoo, S	1
Harada, T; Obayashi, M; Takahara, K; Uzu, T; Yamato, M; Yamauchi, A	1
Adu, D; Dadoniene, J; Dostal, C; Emery, P; Gordon, C; Griffiths, B; Isenberg, DA; Nived, O; Petera, P; Rozman, B; Smolen, JS; Sturfelt, G; Turney, JH; Venalis, A; Yee, CS	1
Chen, W; Liang, L; Xu, H; Yang, X; Ye, Y; Yu, X; Zhan, Z	1
Kawai, S	1
Chiang, BL; Lu, MY; Wang, LC; Yang, YH	1
Korsak, J; Saracyn, M; Wańkowicz, Z	1
Carlavilla, A; González, E; Gutiérrez, E; Morales, E; Ortuño, T; Praga, M	1
Akashi, S; Fujinaga, S; Hira, M; Kaneko, K; Murakami, H; Ohtomo, Y; Takada, M; Yamashiro, Y	1
Yin, PD	1
Diamond, B; Franchin, G	1
Apras, S; Calguneri, M; Ertenli, AI; Kiraz, S; Ozbalkan, Z; Ozturk, MA	1
Assmann, KJ; Berden, JH; Bijl, M; Bruijn, JA; de Glas-Vos, JW; Derksen, RH; Grootscholten, C; Hagen, EC; Ligtenberg, G; van den Wall Bake, AW; van Houwelingen, HC; Weening, JJ	1
Adu, D	1
Berden, JH; Daha, MR; Derksen, RH; Dieker, JW; Grootscholten, C; McGrath, FD; Roos, A; van der Vlag, J	1
Chan, TM	1
Bajema, IM; Berden, JH; Bijl, M; Derksen, RH; Florquin, S; Goldschmeding, R; Grootscholten, C; Hagen, EC; Peutz-Kootstra, CJ; Steenbergen, EJ; Van Houwelingen, HC	1
Hotta, O; Kanno, A; Taguma, Y; Yusa, N	1
Chung, JW; Joe, DY; Kim, HA; Park, HJ; Park, HS; Suh, CH	1
Berden, JH; Bijl, M; Derksen, RH; Grootscholten, C; Snoek, FJ; van Houwelingen, HC	1
Alberighi, OD; Altieri, P; Doria, A; Ferraccioli, G; Ferrara, R; Greco, S; Manno, C; Moroni, G; Mosca, M; Ponticelli, C; Todesco, S	1
Ehara, T; Hirai, K; Hosaka, N; Ikeda, M; Kakegawa, T; Nagata, A; Nishimura, H; Saito, G; Yamazaki, S; Yoshiike, F	1
Harada, K; Takahashi, S; Wada, N	1
Hafeez, F; Saleem, R; Tarar, AM	1
Krane, NK; Meleg-Smith, S; Thakur, V; Wood, H	1
Helmchen, U; Oberle, GP; Stahl, RA	1
Bai, LQ; Chen, XM; Mao, J	1
Hayashi, Y; Kashihara, N; Kira, S; Makino, H; Ota, Z; Shikata, K; Yamasaki, Y	1
Berden, JH; de Glas-Vos, JW; Derksen, RH; Hagen, EC; van den Wall Bake, AW	1
Arisz, L; de Glas-Vos, JW; Krediet, RT; Weening, JJ	1
Ajzen, H; Kirsztajn, G; Monteiro, M; Sato, E; Sesso, R; Silva, L	1
Kiberd, BA; Young, ID	1
Aihara, Y; Ibe, M; Kuriyama, T; Mitsuda, T; Mori, M; Yokota, S	1
De Silvestro, G; Doria, A; Gambari, P; Marson, P; Ossi, E; Piccoli, A; Vaccaro, E; Vesco, P	1
Akizuki, M; Hanaoka, K; Hashimoto, H; Honma, M; Ichikawa, Y; Kashiwazaki, S; Kondo, H; Sugawara, M	1
Chen, XM; Cheng, QL	1
Bertoni, E; Bertoni, M; Brugnolo, F; Emmi, L; Romagnani, S; Salvadori, M	1
Isenberg, DA; Nield, GH; Rankin, EC	1
Ebihara, I; Koide, H; Nakamura, T; Osada, S; Takahashi, T; Tomino, Y; Yamamoto, M	1
Amemiya, K; Inoue, K; Kamata, K; Kobayashi, N; Masaki, Y; Okubo, M	1
Matuszkiewicz-Rowińska, J; Niemczyk, S; Ostrowski, K; Siciński, A; Tomecka, Z; Wardyn, K	1
Bernasconi, S; Casiraghi, F; Gotti, E; Mantovani, A; Noris, M; Remuzzi, G; Sozzani, S	1
Kashihara, N; Makino, H; Ogura, T; Ota, Z; Shikata, K; Sugiyama, H; Yamasaki, Y	1
Ahmad, H; Balachandra, S; Baqi, N; Moazami, S; Singh, A; Tejani, A	1
Abe, S; Gomi, H; Ohno, I; Sakai, O; Shibasaki, T	1
Austin, HA; Balow, JE; Boumpas, DT; Gourley, MF; Klippel, JH; Muir, J; Scott, D; Steinberg, AD; Vaughan, EM; Yarboro, CH	1
Berden, JH; Derksen, RH; Ligtenberg, G	1
Bozić, D; Curić, S; Djisalov, M; Djurdjević-Mirković, T; Fele, D; Ilić, T; Lenert, P; Mitić, I; Sakac, V; Sebić, L; Tepavcević, P; Vodopivec, S	1
Furuichi, K; Hisada, Y; Kobayashi, K; Ohta, S; Segawa, C; Takaeda, M; Wada, T; Yokoyama, H	1
Krane, NK; Meleg-Smith, S	1
Benedetti, G; Bertani, T; Corna, D; Donadelli, R; Guglielmotti, A; Morigi, M; Pinza, M; Remuzzi, G; Zoja, C	1
Banfi, G; Maccario, M; Moroni, G; Ponticelli, C; Quaglini, S	1
Chen, X; Liao, H; Wang, J	1
Funauchi, M; Ikoma, S; Imada, A; Kanamaru, A	1
Diop, TM; Diouf, B; Ka, MM; Pouye, A; Toure, AO	1
Chang, IT; Chen, TW; Liou, HN; Ng, YY; Yang, AH; Yang, WC	1
Banfi, G; Casanova, S; Maccario, M; Moroni, G; Pasquali, S; Ponticelli, C; Quaglini, S; Zucchelli, P	1
Niaudet, P	1
Aihara, Y; Ibe, M; Imagawa, T; Ito, S; Katakura, S; Mitsuda, T; Miyamae, T; Mori, M; Nakasima, S; Tomono, N; Yokota, S	1
Kwinta-Rybicka, J; Sancewicz-Pach, K	1
Ebihara, I; Hara, M; Koide, H; Nakamura, T; Sekizuka, K; Shimada, N; Suzuki, S; Ushiyama, C	1
Chikamori, Y; Iwatani, H; Kakihara, M; Uzu, T; Yamato, M; Yamauchi, A	1
Cetinkaya, R; Kaya, H; Odabas, AR; Selcuk, Y	1
Bilge, I; Emre, S; Kilicaslan, I; Nayir, A; Oktem, F; Sirin, A; Uysal, V	1
Baskin, E; Cila, A; Eren, M; Ozen, S	1
Au, TC; Chan, KW; Ho, CT; Kwan, TH; Lau, CS; Mok, CC; Siu, YP; Wong, RW	1
Austin, HA; Balow, JE; Boumpas, DT; Collins, L; Crane, M; Danning, CL; Gourley, MF; Illei, GG; Klippel, JH; Kuroiwa, T; Steinberg, AD; Vaughan, EM; Yarboro, CH	1
Lewis, EJ	1
Ianushkevich, TN; Kozlovskaia, LV; Krasnova, TN; Samokishina, NA; Shilov, EM; Shvetsov, MIu; Tareeva, IE	1
Tanaka, H; Tateyama, T; Waga, S	1
Chiou, YH; Chiu, PC; Hsieh, KS; Wu, CY	1
Chen, W; Liang, L; Liu, Y; Yang, X; Ye, Y; Yin, P; Yu, X; Zhan, Z	1
Austin, HA; Balow, JE; Boumpas, DT; Crane, M; Danning, CL; Gourley, MF; Illei, GG; Klippel, JH; Kuroiwa, T; Pando, J; Parkin, D; Steinberg, AD; Takada, K; Vaughan, EM; Yarboro, CH	1
Ebihara, I; Koide, H; Nakamura, T; Tomino, Y	1
Austin, HA; Balow, JE; Boumpas, DT; Klippel, JH; Steinberg, AD; Vaughn, EM; Yarboro, CH	1
Bergesio, F; Bertoni, E; Bertoni, M; Emmi, L; Passaleva, A; Rosati, A; Salvadori, M	1
Banfi, G; Moroni, G; Ponticelli, C	2
Gourley, MF; Muir, J; Scott, DE; Steinberg, AD	1
Endoh, M; Miyazaki, M; Niki, H; Nomoto, Y; Sakai, H; Yano, N	1
Kobayashi, M; Koyama, A; Narita, M; Suzuki, M; Suzuki, S; Yamaguchi, N	1
Cameron, JS	1
Fujimi, S; Nagano, Y; Sakemi, T; Uchida, M; Yamaguchi, M	1
Atalá Puigbó, C; Callis Bracons, L; Lara Moctezuma, E; Nieto Rey, J; Solé Mir, E	1
Ianushkevich, TN; Klepikov, PV	1
Sugizaki, T	1
Haramoto, T; Hayashi, Y; Kumagai, I; Makino, H; Ota, Z; Shikata, K; Takahashi, K; Taniai, K; Yamasaki, Y	1
Boey, ML; Feng, PH; Howe, HS	1
Altŭnkova, I; Belovezhdov, N; Monova, D; Robeva, R	1
Chiang, H; Hsu, HC; Lin, CY	1
González-Posada, JM; Hernández Marrero, D; Lorenzo Sellares, V; Losada Cabrera, M; Maceira Cruz, B; Méndez Medina, R; Torres Ramírez, A	1
Harisdangkul, V; Myers, A; Rockhold, L	1
Colasanti, G; D'Amico, G; Ferrario, F; Porri, MT; Quareghi, MI; Rossi, R; Schiaffio, E; Toia, G	1
Chihara, M; Kawaguchi, S; Niinomi, Y; Ueda, N; Yasaki, T; Yoshikawa, T	1
Angiello, G; Quaranta, G; Smurra, G	1
Banfi, G; Cagnoli, L; Moroni, G; Pasquali, S; Ponticelli, C; Zucchelli, P	1
Coratelli, P; Pannarale, G; Rizzi, R	1
Fennell, RS; Garin, EH; Iravani, AA; Richard, GA; Sleasman, JW	1

Reviews

14 review(s) available for methylprednisolone and Lupus Nephritis

Article	Year
Pulmonary mucormycosis in systemic lupus erythematosus: successful management of a case along with review of literature. Clinical rheumatology, 2022, Volume: 41, Issue:1 Topics: Adult; Cyclophosphamide; Female; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Mucormycosis; Young Adult	2022
Systemic lupus erythematosus and diffuse alveolar hemorrhage, etiology and novel treatment strategies. Lupus, 2020, Volume: 29, Issue:4 Topics: Adolescent; Adult; Capillaries; Complement C3; Cyclophosphamide; Dyspnea; Female; Glucocorticoids; Hemoglobins; Hemoptysis; Hemorrhage; Humans; Immunologic Factors; Immunosuppressive Agents; Lung Diseases; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methylprednisolone; Plasmapheresis; Pulmonary Diffusing Capacity; Rituximab; Thrombocytopenia	2020
Eurolupus cyclophosphamide plus repeated pulses of methyl-prednisolone for the induction therapy of class III, IV and V lupus nephritis. Autoimmunity reviews, 2021, Volume: 20, Issue:10 Topics: Cyclophosphamide; Humans; Immunosuppressive Agents; Induction Chemotherapy; Lupus Nephritis; Methylprednisolone; Mycophenolic Acid; Observational Studies as Topic; Remission Induction; Treatment Outcome	2021
[Case of lupus nephritis and enteritis associated with bilateral hydronephrosis]. Nihon Jinzo Gakkai shi, 2009, Volume: 51, Issue:5 Topics: Adult; Enteritis; Female; Humans; Hydronephrosis; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Nephrotic Syndrome; Prednisolone; Pulse Therapy, Drug	2009
[New insight into nephrotic lupus glomerulonephritis]. Nihon Jinzo Gakkai shi, 2010, Volume: 52, Issue:7 Topics: Azathioprine; Blood Component Removal; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Japan; Lupus Nephritis; Methylprednisolone; Prednisolone; Pulse Therapy, Drug	2010
[Two cases of lupus cystitis complicated by lupus nephritis treated successfully with steroid therapy]. Nihon Jinzo Gakkai shi, 2003, Volume: 45, Issue:8 Topics: Adult; Anti-Inflammatory Agents; Cystitis, Interstitial; Female; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Middle Aged; Prednisolone; Pulse Therapy, Drug	2003
[Nephropathies in patients with collagen diseases]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 6 Topics: Combined Modality Therapy; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Prednisolone; Pulse Therapy, Drug; Renal Dialysis; Scleroderma, Systemic; Vasculitis	2004
Pulse steroids: how much is enough? Autoimmunity reviews, 2006, Volume: 5, Issue:2 Topics: Clinical Trials as Topic; Glucocorticoids; Humans; Infections; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Treatment Outcome	2006
[Lupus nephritis]. Der Internist, 1995, Volume: 36, Issue:3 Topics: Antibodies, Antinuclear; Biopsy; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Kidney; Kidney Function Tests; Lupus Nephritis; Methylprednisolone; Prednisone	1995
[Treatment of nephritis in systemic lupus erythematodes]. Nederlands tijdschrift voor geneeskunde, 1996, Sep-28, Volume: 140, Issue:39 Topics: Anti-Inflammatory Agents; Biopsy; Cyclophosphamide; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Kidney Glomerulus; Lupus Nephritis; Methylprednisolone; Randomized Controlled Trials as Topic	1996
[Methylprednisolone pulse therapy in the early phases of lupus nephritis]. Srpski arhiv za celokupno lekarstvo, 1996, Volume: 124 Suppl 1 Topics: Adolescent; Adult; Female; Humans; Infusions, Intravenous; Lupus Nephritis; Male; Methylprednisolone	1996
[Treatment of lupus nephritis in children]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1999, Volume: 6, Issue:12 Topics: Adrenal Cortex Hormones; Adult; Age Factors; Anti-Inflammatory Agents; Antirheumatic Agents; Azathioprine; Biopsy; Child; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Kidney; Lupus Nephritis; Male; Methylprednisolone; Prognosis	1999
[Lupus nephropathy in children. Based on the authors' caseload]. Anales espanoles de pediatria, 1990, Volume: 33, Issue:5 Topics: Child; Child, Preschool; Cyclophosphamide; Female; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methylprednisolone	1990
Long-term prognosis of diffuse lupus nephritis. Clinical nephrology, 1987, Volume: 28, Issue:6 Topics: Administration, Oral; Adolescent; Adult; Creatinine; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Kidney; Kidney Function Tests; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Prednisone; Prognosis; Proteinuria	1987

Trials

34 trial(s) available for methylprednisolone and Lupus Nephritis

Article	Year
A randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritis. Annals of the rheumatic diseases, 2017, Volume: 76, Issue:8 Topics: Adult; Cyclophosphamide; Double-Blind Method; Drug Therapy, Combination; Early Termination of Clinical Trials; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Induction Chemotherapy; Lupus Nephritis; Maintenance Chemotherapy; Male; Mesenchymal Stem Cell Transplantation; Methylprednisolone; Mycophenolic Acid; Remission Induction; Transplantation, Homologous; Treatment Outcome; Umbilical Cord; Young Adult	2017
Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis. Lupus, 2013, Volume: 22, Issue:6 Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Cyclophosphamide; Disease Progression; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunologic Factors; Immunosuppressive Agents; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Prospective Studies; Remission Induction; Rituximab; Severity of Illness Index; Treatment Outcome; Young Adult	2013
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids. Annals of the rheumatic diseases, 2013, Volume: 72, Issue:8 Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Cohort Studies; Creatine; Drug Substitution; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Prospective Studies; Proteinuria; Remission Induction; Rituximab; Treatment Outcome; Young Adult	2013
Multitarget therapy for induction treatment of lupus nephritis: a randomized trial. Annals of internal medicine, 2015, Jan-06, Volume: 162, Issue:1 Topics: Adolescent; Adult; Aged; Biopsy; Cyclophosphamide; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Pilot Projects; Prednisone; Prospective Studies; Remission Induction; Tacrolimus; Young Adult	2015
Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis. Kidney international, 2016, Volume: 89, Issue:1 Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Drug Costs; Female; Gastrointestinal Diseases; Humans; Immunosuppressive Agents; Induction Chemotherapy; Lupus Nephritis; Maintenance Chemotherapy; Male; Methylprednisolone; Mycophenolic Acid; Severity of Illness Index; Treatment Outcome; Young Adult	2016
Is combination rituximab with cyclophosphamide better than rituximab alone in the treatment of lupus nephritis? Rheumatology (Oxford, England), 2009, Volume: 48, Issue:8 Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; B-Lymphocytes; Biomarkers; Chi-Square Distribution; Creatinine; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Lupus Nephritis; Lymphocyte Count; Male; Methylprednisolone; Middle Aged; Remission Induction; Rituximab; Statistics, Nonparametric; Time Factors; Treatment Outcome; Young Adult	2009
Combination therapy with steroids and mizoribine in juvenile SLE: a randomized controlled trial. Pediatric nephrology (Berlin, Germany), 2010, Volume: 25, Issue:5 Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Age of Onset; Child; Disease-Free Survival; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Japan; Kaplan-Meier Estimate; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methylprednisolone; Prednisolone; Proteinuria; Pulse Therapy, Drug; Recurrence; Ribonucleosides; Time Factors; Treatment Outcome	2010
Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis. Annals of the rheumatic diseases, 2012, Volume: 71, Issue:6 Topics: Adolescent; Adult; Anti-Inflammatory Agents; Azathioprine; Creatinine; Cyclophosphamide; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Prognosis; Proteinuria; Time Factors; Treatment Outcome; Young Adult	2012
Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylprednisolone. Lupus, 2003, Volume: 12, Issue:4 Topics: Adolescent; Adult; Anti-Inflammatory Agents; Autoantibodies; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Proteinuria; Pulse Therapy, Drug; Recurrence; Remission Induction; Treatment Outcome	2003
EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis. Annals of the rheumatic diseases, 2004, Volume: 63, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Aged; Antirheumatic Agents; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Prednisolone; Treatment Outcome	2004
Intensified, intermittent, low-dose intravenous cyclophosphamide together with oral alternate-day steroid therapy in lupus nephritis (long-term outcome). Clinical rheumatology, 2006, Volume: 25, Issue:6 Topics: Administration, Oral; Adult; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Gastrointestinal Diseases; Glucocorticoids; Hematuria; Humans; Hypertension; Immunosuppressive Agents; Injections, Intravenous; Leukopenia; Longitudinal Studies; Lupus Nephritis; Male; Menstruation Disturbances; Methylprednisolone; Middle Aged; Obesity; Treatment Outcome	2006
Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial. Kidney international, 2006, Volume: 70, Issue:4 Topics: Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents; Azathioprine; Creatinine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Prednisolone; Remission Induction; Treatment Outcome	2006
A prospective study of anti-chromatin and anti-C1q autoantibodies in patients with proliferative lupus nephritis treated with cyclophosphamide pulses or azathioprine/methylprednisolone. Annals of the rheumatic diseases, 2007, Volume: 66, Issue:5 Topics: Anti-Inflammatory Agents; Autoantibodies; Azathioprine; Biomarkers; Chromatin; Complement C1q; Cyclophosphamide; DNA; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lupus Nephritis; Methylprednisolone; Nucleosomes; Prospective Studies	2007
Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis. Arthritis and rheumatism, 2007, Volume: 56, Issue:3 Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Biopsy; Creatinine; Cyclophosphamide; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney; Lupus Nephritis; Male; Methylprednisolone; Multivariate Analysis; Treatment Outcome	2007
Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/ methylprednisolone in a randomized controlled trial. The Journal of rheumatology, 2007, Volume: 34, Issue:8 Topics: Adult; Antirheumatic Agents; Azathioprine; Cost of Illness; Cyclophosphamide; Female; Health Status; Humans; Lupus Nephritis; Male; Methylprednisolone; Pain Measurement; Prospective Studies; Quality of Life; Severity of Illness Index; Treatment Outcome	2007
A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years. Clinical journal of the American Society of Nephrology : CJASN, 2006, Volume: 1, Issue:5 Topics: Administration, Oral; Adult; Azathioprine; Complement C3; Complement C4; Creatinine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Italy; Lupus Nephritis; Male; Methylprednisolone; Pilot Projects; Prednisone; Prospective Studies; Proteinuria; Severity of Illness Index; Time Factors; Treatment Outcome	2006
Treatment of proliferative lupus nephritis with methylprednisolone pulse therapy and oral azathioprine. The Netherlands journal of medicine, 1995, Volume: 46, Issue:1 Topics: Adolescent; Adult; Azathioprine; Creatinine; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephritis; Humans; Infusions, Intravenous; Lupus Nephritis; Male; Methylprednisolone; Middle Aged	1995
A controlled trial of pulse cyclophosphamide versus pulse methylprednisolone in severe lupus nephritis. Lupus, 1994, Volume: 3, Issue:2 Topics: Adult; Creatinine; Cyclophosphamide; Dose-Response Relationship, Drug; Female; Humans; Lupus Nephritis; Male; Methylprednisolone	1994
[Evaluation of serum C3 and CH50 levels as markers of disease-activity and indicators of efficacy of treatment of lupus nephritis in childhood]. Ryumachi. [Rheumatism], 1994, Volume: 34, Issue:4 Topics: Adolescent; Age of Onset; Child; Complement C3; Complement Hemolytic Activity Assay; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Lupus Nephritis; Male; Methylprednisolone; Prednisolone; Severity of Illness Index	1994
Therapy of lupus nephritis. A two-year prospective study. Annales de medecine interne, 1994, Volume: 145, Issue:5 Topics: Adolescent; Adult; Aged; Azathioprine; Combined Modality Therapy; Drug Therapy, Combination; Humans; Kidney; Lupus Nephritis; Methylprednisolone; Middle Aged; Plasmapheresis; Prednisone; Prospective Studies; Treatment Outcome	1994
[Double blind trial of pulse methylprednisolone versus conventional oral prednisolone in lupus nephritis]. Ryumachi. [Rheumatism], 1994, Volume: 34, Issue:3 Topics: Administration, Oral; Adolescent; Adult; Aged; Double-Blind Method; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Prednisolone; Prospective Studies	1994
Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial. Annals of internal medicine, 1996, Oct-01, Volume: 125, Issue:7 Topics: Adult; Anti-Inflammatory Agents; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Life Tables; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Remission Induction	1996
Glomerular ICAM-1 expression related to circulating TNF-alpha in human glomerulonephritis. Nephron, 1997, Volume: 76, Issue:4 Topics: Adolescent; Adult; Aged; Anti-Glomerular Basement Membrane Disease; Anti-Inflammatory Agents; Child; Female; Glomerulonephritis; Hematuria; Humans; Immunohistochemistry; Intercellular Adhesion Molecule-1; Kidney Glomerulus; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Tumor Necrosis Factor-alpha; Urinalysis; Vasculitis	1997
[Improvement of the maintenance therapy after methylprednisolone pulse therapy--effect of prednisolone combined with immunosuppressants]. Ryumachi. [Rheumatism], 1999, Volume: 39, Issue:6 Topics: Adolescent; Anti-Inflammatory Agents; Child; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Methylprednisolone; Prednisolone; Pulse Therapy, Drug; Remission Induction; Ribonucleosides; Secondary Prevention	1999
Urinary podocytes for the assessment of disease activity in lupus nephritis. The American journal of the medical sciences, 2000, Volume: 320, Issue:2 Topics: Adult; Antibodies, Monoclonal; Cytoskeletal Proteins; Female; Fluorescent Antibody Technique; Humans; Kidney Glomerulus; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Predictive Value of Tests; Prednisolone; Sialoglycoproteins; Treatment Outcome; Urine	2000
Treatment of diffuse proliferative lupus glomerulonephritis: a comparison of two cyclophosphamide-containing regimens. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001, Volume: 38, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Azathioprine; Biopsy; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Kidney; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Plasmapheresis; Pulse Therapy, Drug; Recurrence; Regression Analysis; Remission Induction	2001
Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Annals of internal medicine, 2001, Aug-21, Volume: 135, Issue:4 Topics: Adult; Anti-Inflammatory Agents; Creatinine; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Infusions, Intravenous; Lupus Nephritis; Male; Methylprednisolone; Prednisone; Remission Induction; Survival Analysis; Treatment Failure	2001
Methylprednisolone pulse therapy in Japanese children with severe lupus nephritis. Pediatric nephrology (Berlin, Germany), 2001, Volume: 16, Issue:10 Topics: Adolescent; Anti-Inflammatory Agents; Child, Preschool; Female; Humans; Injections, Intravenous; Japan; Kidney; Lupus Nephritis; Male; Methylprednisolone; Proteinuria	2001
Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies. Arthritis and rheumatism, 2002, Volume: 46, Issue:4 Topics: Adult; Anti-Inflammatory Agents; Cohort Studies; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Nephritis; Male; Methylprednisolone; Predictive Value of Tests; Prevalence; Pulse Therapy, Drug; Recurrence; Treatment Outcome	2002
Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet (London, England), 1992, Sep-26, Volume: 340, Issue:8822 Topics: Adolescent; Adult; Child; Creatinine; Cyclophosphamide; Drug Administration Schedule; Female; Humans; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Recurrence; Survival Analysis; Treatment Outcome	1992
Treatment of diffuse proliferative lupus nephritis. Contributions to nephrology, 1992, Volume: 99 Topics: Adult; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Injections, Intravenous; Lupus Nephritis; Male; Methylprednisolone; Prednisone; Time Factors	1992
Approach to lupus nephritis based upon randomized trials. Contributions to nephrology, 1992, Volume: 99 Topics: Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lupus Nephritis; Male; Methylprednisolone; Prednisone	1992
[Lupus nephropathy in children. Based on the authors' caseload]. Anales espanoles de pediatria, 1990, Volume: 33, Issue:5 Topics: Child; Child, Preschool; Cyclophosphamide; Female; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methylprednisolone	1990
Lupus nephritis: efficacy of monthly pulse therapy with intravenous methylprednisolone. Southern medical journal, 1989, Volume: 82, Issue:3 Topics: Acute Disease; Adolescent; Adult; Child; Creatinine; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Lupus Nephritis; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Middle Aged; Random Allocation; Time Factors	1989

Other Studies

122 other study(ies) available for methylprednisolone and Lupus Nephritis

Article	Year
75-Year-Old Man With Fever and Malaise. Mayo Clinic proceedings, 2021, Volume: 96, Issue:11 Topics: Acute Kidney Injury; Aged; Antirheumatic Agents; Diagnosis, Differential; Humans; Hydroxychloroquine; Immunologic Tests; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methylprednisolone; Mycophenolic Acid; Pleural Effusion; Prognosis; Remission Induction; Renal Dialysis	2021
Lupus nephritis with corticosteroid responsiveness: molecular changes of CD46-mediated type 1 regulatory T cells. Pediatric research, 2022, Volume: 92, Issue:4 Topics: Adrenal Cortex Hormones; CD4-Positive T-Lymphocytes; Child; Humans; Interleukin-10; Leukocytes, Mononuclear; Lupus Nephritis; Membrane Cofactor Protein; Methylprednisolone; Protein Isoforms; Proto-Oncogene Proteins c-akt; Receptors, CCR7; T-Lymphocytes, Regulatory	2022
HSPB5 suppresses renal inflammation and protects lupus-prone NZB/W F1 mice from severe renal damage. Arthritis research & therapy, 2022, 12-12, Volume: 24, Issue:1 Topics: alpha-Crystallin B Chain; Animals; Disease Models, Animal; Interleukin-6; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Mice; Mice, Inbred NZB; Proteinuria	2022
[Efficacy and safety of half-dose rituximab in the treatment of 23 cases with lupus nephritis]. Zhonghua nei ke za zhi, 2023, Jan-01, Volume: 62, Issue:1 Topics: Creatinine; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Rituximab; Treatment Outcome	2023
Polyneuritis cranialis as a unique initial presentation of juvenile systemic lupus erythematosus: Case report. Lupus, 2023, Volume: 32, Issue:14 Topics: Adolescent; Child; Female; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Mycophenolic Acid; Neuritis	2023
A case of membranous nephropathy diagnosed with lupus nephritis 11 years after onset. CEN case reports, 2019, Volume: 8, Issue:4 Topics: Adult; Antibodies, Antinuclear; Drug Therapy, Combination; Enzyme Inhibitors; Female; Glomerulonephritis, Membranous; Glucocorticoids; Hospitalization; Humans; Immunoglobulin G; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Mycophenolic Acid; Nephrotic Syndrome; Proteinuria; Recurrence; Remission Induction	2019
Risk factors of infection-associated mortality in children with lupus nephritis in under-resourced areas. Lupus, 2019, Volume: 28, Issue:14 Topics: Adolescent; Child; Cross Infection; Cyclophosphamide; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Logistic Models; Lupus Nephritis; Male; Methylprednisolone; Multivariate Analysis; Mycoses; Prednisolone; Retrospective Studies; Risk Factors; Thailand	2019
Cerebral venous sinus thrombosis as the initial presentation of systemic lupus erythematosus. Lupus, 2020, Volume: 29, Issue:2 Topics: Adult; Anticoagulants; Humans; Kidney; Lupus Nephritis; Magnetic Resonance Imaging; Male; Methylprednisolone; Microscopy, Electron; Sinus Thrombosis, Intracranial	2020
Induction therapy with rituximab for lupus nephritis due to prolidase deficiency. Rheumatology (Oxford, England), 2020, Oct-01, Volume: 59, Issue:10 Topics: Administration, Intravenous; Administration, Oral; Adolescent; Antibiotics, Antineoplastic; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunologic Factors; Induction Chemotherapy; Lupus Nephritis; Male; Methylprednisolone; Mycophenolic Acid; Prednisolone; Prolidase Deficiency; Rituximab; Skin Ulcer; Treatment Outcome	2020
Per-protocol repeat kidney biopsy portends relapse and long-term outcome in incident cases of proliferative lupus nephritis. Rheumatology (Oxford, England), 2020, 11-01, Volume: 59, Issue:11 Topics: Adult; Biopsy; Creatinine; Cyclophosphamide; Disease Progression; Female; Glucocorticoids; Humans; Immunologic Factors; Immunosuppressive Agents; Kidney; Kidney Tubules; Lupus Nephritis; Male; Methylprednisolone; Mycophenolic Acid; Prognosis; Proportional Hazards Models; Proteinuria; Pulse Therapy, Drug; Recurrence; Retrospective Studies; Rituximab; Young Adult	2020
Repeated pulses of methyl-prednisolone with reduced doses of prednisone improve the outcome of class III, IV and V lupus nephritis: An observational comparative study of the Lupus-Cruces and lupus-Bordeaux cohorts. Autoimmunity reviews, 2017, Volume: 16, Issue:8 Topics: Adult; Anti-Inflammatory Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Prednisone; Remission Induction; Young Adult	2017
Pulmonary lymphangioleimyomatosis and systemic lupus erythematosus in a menopausal woman. BMC nephrology, 2018, 04-18, Volume: 19, Issue:1 Topics: Anti-Bacterial Agents; Cyclophosphamide; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Leiomyomatosis; Lung Neoplasms; Lupus Nephritis; Lymphangioma; Menopause; Methylprednisolone; Middle Aged; Mycophenolic Acid; Pneumonia, Bacterial; Prednisolone	2018
Podocyte foot process width is a prediction marker for complete renal response at 6 and 12 months after induction therapy in lupus nephritis. Clinical immunology (Orlando, Fla.), 2018, Volume: 197 Topics: Adult; Creatinine; Cyclophosphamide; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Logistic Models; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Podocytes; Prednisolone; Prognosis; Proteinuria; Remission Induction; Retrospective Studies; Severity of Illness Index; Tacrolimus	2018
How do lupus glomerulonephritis and its treatment affect the renal reserve? International urology and nephrology, 2019, Volume: 51, Issue:2 Topics: Adult; Biopsy; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney; Kidney Function Tests; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Mycophenolic Acid; Recovery of Function; Treatment Outcome	2019
Analysis of HLA-G expression in renal tissue in lupus nephritis: a pilot study. Lupus, 2019, Volume: 28, Issue:9 Topics: Adult; Anti-Inflammatory Agents; Biopsy; Female; Follow-Up Studies; HLA-G Antigens; Humans; Immunologic Factors; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Pilot Projects; Retrospective Studies; Rituximab; Treatment Outcome; Young Adult	2019
Progressive improvement of patient and renal survival and reduction of morbidity over time in patients with lupus nephritis (LN) followed for 20 years. Lupus, 2013, Volume: 22, Issue:8 Topics: Adolescent; Adult; Creatinine; Female; Follow-Up Studies; Glucocorticoids; Hematocrit; Humans; Italy; Kidney Failure, Chronic; Life Expectancy; Lupus Nephritis; Male; Methylprednisolone; Nephrotic Syndrome; Outcome Assessment, Health Care; Renal Insufficiency; Survival Rate; Time Factors; Young Adult	2013
Late response to rituximab in a dialysis patient with severe lupus nephritis. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2013, Volume: 24, Issue:5 Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Cyclophosphamide; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Nephritis; Methylprednisolone; Recovery of Function; Renal Dialysis; Rituximab; Treatment Failure	2013
Prednisone in lupus nephritis: how much is enough? Autoimmunity reviews, 2014, Volume: 13, Issue:2 Topics: Adult; Cyclophosphamide; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Kidney; Lupus Nephritis; Male; Methylprednisolone; Prednisone; Remission Induction	2014
CD8⁺ Treg cells associated with decreasing disease activity after intravenous methylprednisolone pulse therapy in lupus nephritis with heavy proteinuria. PloS one, 2014, Volume: 9, Issue:1 Topics: Administration, Intravenous; Adolescent; Apoptosis; CD8-Positive T-Lymphocytes; Cell Count; Forkhead Transcription Factors; Granzymes; Humans; Interleukin-10; Lupus Nephritis; Methylprednisolone; Proteinuria; Pulse Therapy, Drug; RNA, Small Interfering	2014
Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis. Modern rheumatology, 2015, Volume: 25, Issue:2 Topics: Adolescent; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methylprednisolone; Mycophenolic Acid; Retrospective Studies; Treatment Outcome	2015
A Wolf in Infection's Clothing: The Difficulties of Discerning Systemic Lupus Erythematosus from Its Infectious Sequelae. The American journal of medicine, 2015, Volume: 128, Issue:7 Topics: Abdominal Pain; Biopsy, Needle; Clostridioides difficile; Diagnosis, Differential; Diarrhea; Enterocolitis, Pseudomembranous; Female; Follow-Up Studies; Ganciclovir; Humans; Kidney Function Tests; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Middle Aged; Prednisolone; Recurrence; Risk Assessment; Severity of Illness Index; Treatment Outcome; Vancomycin	2015
Therapeutic effect of double-filtration plasmapheresis combined with methylprednisolone to treat diffuse proliferative lupus nephritis. Journal of clinical apheresis, 2016, Volume: 31, Issue:4 Topics: Case-Control Studies; Dose-Response Relationship, Drug; Humans; Lupus Nephritis; Methylprednisolone; Mycophenolic Acid; Plasmapheresis; Remission Induction; Secondary Prevention; Treatment Outcome	2016
Distinct effects of mycophenolate mofetil and cyclophosphamide on renal fibrosis in NZBWF1/J mice. Autoimmunity, 2015, Volume: 48, Issue:7 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Proliferation; Cyclophosphamide; Disease Models, Animal; Disease Progression; Female; Fibronectins; Fibrosis; Gene Expression Regulation; Humans; Immunosuppressive Agents; Interleukin-6; Kidney; Kidney Function Tests; Lupus Nephritis; Male; Mesangial Cells; Methylprednisolone; Mice; Mycophenolic Acid; Protein Kinase C-alpha; Survival Analysis; Transforming Growth Factor beta1	2015
Methylprednisolone attenuates lipopolysaccharide-induced Fractalkine expression in kidney of Lupus-prone MRL/lpr mice through the NF-kappaB pathway. BMC nephrology, 2015, Aug-27, Volume: 16 Topics: Animals; Chemokine CX3CL1; Female; Glucocorticoids; Kidney; Lipopolysaccharides; Lupus Nephritis; Methylprednisolone; Mice; Mice, Inbred MRL lpr; NF-kappa B; Random Allocation; Signal Transduction	2015
Long-term outcomes with multi-targeted immunosuppressive protocol in children with severe proliferative lupus nephritis. Lupus, 2016, Volume: 25, Issue:4 Topics: Administration, Intravenous; Adolescent; Age Factors; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Female; Follow-Up Studies; Hospitalization; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Logistic Models; Lupus Nephritis; Male; Methylprednisolone; Mycophenolic Acid; Pulse Therapy, Drug; Recurrence; Remission Induction; Risk Factors; Severity of Illness Index; Singapore; Time Factors; Treatment Outcome	2016
The short-term efficacy of bortezomib combined with glucocorticoids for the treatment of refractory lupus nephritis. Lupus, 2017, Volume: 26, Issue:9 Topics: Administration, Intravenous; Adult; Antineoplastic Agents; Autoantibodies; Bortezomib; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney; Lupus Nephritis; Male; Methylprednisolone; Prednisone; Proteinuria; Remission Induction	2017
Efficacy and safety of rituximab in comparison with common induction therapies in pediatric active lupus nephritis. Pediatric nephrology (Berlin, Germany), 2017, Volume: 32, Issue:6 Topics: Child; Child, Preschool; Clinical Protocols; Cyclophosphamide; Disease-Free Survival; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Methylprednisolone; Mycophenolic Acid; Prednisone; Remission Induction; Retrospective Studies; Rituximab; Survival Analysis; Treatment Outcome	2017
Long-term efficacy and safety of quadruple therapy in childhood diffuse proliferative lupus nephritis. Renal failure, 2008, Volume: 30, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Biopsy, Needle; Chi-Square Distribution; Child; Child, Preschool; Cohort Studies; Cyclophosphamide; Dipyridamole; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Kidney Function Tests; Lupus Nephritis; Male; Methylprednisolone; Probability; Recurrence; Retrospective Studies; Risk Assessment; Severity of Illness Index; Survival Rate; Time Factors; Treatment Outcome	2008
Myasthenia gravis associated with lupus nephritis. Lupus, 2008, Volume: 17, Issue:9 Topics: Cholinesterase Inhibitors; Fatal Outcome; Female; Genetic Predisposition to Disease; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Myasthenia Gravis; Mycophenolic Acid; Pyridostigmine Bromide; Siblings; Thymectomy; Young Adult	2008
Bullous systemic lupus erythematosus induced by the therapy for lupus nephritis. International journal of dermatology, 2008, Volume: 47, Issue:12 Topics: Adult; Blister; Cyclophosphamide; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Erythematosus, Cutaneous; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methylprednisolone	2008
[Relationship between initial diagnosis and long-term prognosis in lupus nephritis]. Nihon Jinzo Gakkai shi, 2009, Volume: 51, Issue:1 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Child; Creatinine; Female; Humans; Immunosuppressive Agents; Kidney; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Survival Rate; Young Adult	2009
Short-term, high-dose systemic steroids and intraocular pressure. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2009, Volume: 44, Issue:4 Topics: Adult; Female; Glucocorticoids; Humans; Intraocular Pressure; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methylprednisolone; Nervous System Diseases; Pulse Therapy, Drug; Thrombocytopenia; Tonometry, Ocular	2009
[Severe systemic lupus erythematosus induced by isoniazide]. Revue de pneumologie clinique, 2009, Volume: 65, Issue:6 Topics: Anti-Inflammatory Agents; Antibodies, Antinuclear; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Lupus Erythematosus, Systemic; Lupus Nephritis; Madagascar; Methylprednisolone; Tuberculosis, Pleural; Young Adult	2009
[Longstanding intractable massive ascites caused by chronic lupus peritonitis with nephrotic syndrome: a case report]. Nihon Jinzo Gakkai shi, 2009, Volume: 51, Issue:8 Topics: Adult; Ascites; Chronic Disease; Female; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Nephrotic Syndrome; Peritonitis; Pulse Therapy, Drug; Time Factors; Treatment Outcome	2009
Acute lupus hemophagocytic syndrome: report of a case. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2010, Volume: 30, Issue:2 Topics: Acute Disease; Adult; Autoantibodies; Bone Marrow; Cyclophosphamide; Female; Ferritins; Histiocytes; Humans; Immunosuppressive Agents; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymphohistiocytosis, Hemophagocytic; Mesangial Cells; Methylprednisolone	2010
Long-term outcome of patients with lupus nephritis: a single center experience. Bosnian journal of basic medical sciences, 2010, Volume: 10 Suppl 1 Topics: Adult; Cyclophosphamide; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Inflammation; Lupus Nephritis; Male; Methylprednisolone; Mycophenolic Acid; Proteinuria; Remission Induction; Time Factors; Treatment Outcome	2010
An unusual case of ANA negative systemic lupus erythematosus presented with vasculitis, long-standing serositis and full-house nephropathy. Rheumatology international, 2013, Volume: 33, Issue:1 Topics: Administration, Oral; Adolescent; Antibodies, Antinuclear; Azathioprine; Cyclophosphamide; Dipyridamole; Drug Therapy, Combination; Glomerulonephritis, Membranoproliferative; Glucocorticoids; Humans; Immunosuppressive Agents; Injections, Intravenous; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methylprednisolone; Peritonitis; Prednisolone; Pulse Therapy, Drug; Renal Insufficiency; Treatment Outcome; Vasculitis	2013
Development of systemic lupus erythematosus in a patient with hypoparathyroidism: a case report and review of the literature. International journal of rheumatic diseases, 2010, Volume: 13, Issue:2 Topics: Adult; Cyclophosphamide; Female; Glucocorticoids; Humans; Hypoparathyroidism; Immunosuppressive Agents; Lupus Nephritis; Methylprednisolone; Pulse Therapy, Drug; Seizures	2010
Measurement of interleukin-1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease. Human immunology, 2010, Volume: 71, Issue:9 Topics: Adult; beta 2-Glycoprotein I; Biomarkers; C-Reactive Protein; Creatinine; Cyclophosphamide; Cyclosporine; Female; Glomerular Filtration Rate; Humans; Interleukin 1 Receptor Antagonist Protein; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Metabolic Clearance Rate; Methylprednisolone; Middle Aged; Proteinuria; Severity of Illness Index; Young Adult	2010
Diffuse alveolar hemorrhage in lupus nephritis complicated by microscopic polyangiitis. Clinical and experimental nephrology, 2011, Volume: 15, Issue:2 Topics: Aged; Antibodies, Antineutrophil Cytoplasmic; Fatal Outcome; Female; Hemorrhage; Humans; Lung Diseases; Lupus Nephritis; Methylprednisolone; Microscopic Polyangiitis; Peroxidase; Plasma Exchange; Pulmonary Alveoli	2011
Cytomegalovirus colitis. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2011, Volume: 31, Issue:1 Topics: Antigens, Viral; Colitis; Colonoscopy; Cytomegalovirus; Cytomegalovirus Infections; Diagnosis, Differential; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Mycophenolic Acid; Nocardia Infections; Opportunistic Infections; Pneumatosis Cystoides Intestinalis; Respiratory Tract Infections	2011
Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2011, Volume: 26, Issue:12 Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Cyclophosphamide; Female; Glucocorticoids; Humans; Immunologic Factors; Immunosuppression Therapy; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Prospective Studies; Remission Induction; Rituximab; Time Factors	2011
[Cyclophosphamide-induced lupus flare in diffuse proliferative lupus nephropathy]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2011, Volume: 31, Issue:2 Topics: Acute Disease; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Edema; Emergencies; Hematuria; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methylprednisolone; Nephrotic Syndrome; Prednisone; Young Adult	2011
Intracranial hypertension with delayed puberty: a rare presentation of juvenile onset systemic lupus erythematosus. Singapore medical journal, 2012, Volume: 53, Issue:1 Topics: Adolescent; Anti-Inflammatory Agents; Antibodies, Antinuclear; Biopsy; Blood Sedimentation; Brain; Humans; Intracranial Hypertension; Lupus Erythematosus, Systemic; Lupus Nephritis; Magnetic Resonance Imaging; Male; Methylprednisolone; Puberty, Delayed	2012
Haemolytic-uraemic syndrome during severe lupus nephritis: efficacy of plasma exchange. Internal medicine journal, 2012, Volume: 42, Issue:1 Topics: Acute Kidney Injury; Adult; Biopsy; Combined Modality Therapy; Cyclophosphamide; Drug Therapy, Combination; Erythrocytes, Abnormal; Female; Hemolytic-Uremic Syndrome; Humans; Hydroxychloroquine; Immunosuppressive Agents; Kidney; Lupus Nephritis; Methylprednisolone; Models, Immunological; Mycophenolic Acid; Plasma Exchange; Prednisone	2012
Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis. Clinical and experimental nephrology, 2012, Volume: 16, Issue:5 Topics: Adrenal Cortex Hormones; Adult; Aged; Creatinine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Middle Aged; Pilot Projects; Prednisolone; Proteinuria; Remission Induction; Retrospective Studies; Ribonucleosides; Tacrolimus; Treatment Outcome	2012
Rituximab induced pulmonary fibrosis in a patient with lupus nephritis. Lupus, 2012, Volume: 21, Issue:10 Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal, Murine-Derived; Female; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Pulmonary Fibrosis; Rituximab	2012
[Mycophenolate mofetil in induction and maintenance therapy for juvenile onset severe lupus nephritis]. Nihon Jinzo Gakkai shi, 2012, Volume: 54, Issue:2 Topics: Adolescent; Child; Female; Humans; Induction Chemotherapy; Lupus Nephritis; Maintenance Chemotherapy; Male; Methylprednisolone; Mycophenolic Acid; Prednisolone; Pulse Therapy, Drug; Severity of Illness Index; Time Factors; Treatment Outcome	2012
Atypical presentation of neuropsychiatric lupus with acanthosis nigricans. Pediatric neurology, 2012, Volume: 47, Issue:4 Topics: Acanthosis Nigricans; Adrenoleukodystrophy; Atrophy; Autoantibodies; Cerebral Cortex; Child; Cognition Disorders; Corpus Callosum; Diagnosis, Differential; Disease Progression; Epilepsy, Tonic-Clonic; Fornix, Brain; Humans; Immunosuppressive Agents; Intelligence; Lupus Erythematosus, Systemic; Lupus Nephritis; Magnetic Resonance Imaging; Male; Methylprednisolone; Remission Induction; Ribosomal Proteins	2012
A girl with difficult lupus nephritis: lupus vasculopathy. Clinical and experimental nephrology, 2012, Volume: 16, Issue:6 Topics: Adolescent; Antibodies, Monoclonal, Murine-Derived; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Methylprednisolone; Plasma Exchange; Renal Insufficiency, Chronic; Rituximab; Severity of Illness Index; Treatment Outcome; Vascular Diseases	2012
Intravenous cyclophosphamide combined with steroids in pediatric onset severe lupus nephritis. International urology and nephrology, 2013, Volume: 45, Issue:5 Topics: Administration, Intravenous; Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Creatinine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Lupus Nephritis; Male; Methylprednisolone; Prednisolone; Proteinuria; Recurrence; Retrospective Studies; Severity of Illness Index; Survival Rate; Treatment Outcome	2013
Lupus nephritis and non-Hodgkin lymphoma simultaneously diagnosed in a patient on methimazole. Lupus, 2013, Volume: 22, Issue:1 Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antithyroid Agents; Biopsy, Needle; Bone Marrow Examination; Cyclophosphamide; Drug Therapy, Combination; Graves Disease; Humans; Immunosuppressive Agents; Lupus Nephritis; Lymphoma, B-Cell; Male; Methimazole; Methylprednisolone; Renal Dialysis; Risk Factors; Rituximab; Treatment Outcome	2013
Long-term renal outcome and complications in South Africans with proliferative lupus nephritis. International urology and nephrology, 2013, Volume: 45, Issue:5 Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Blood Pressure; Creatinine; Cyclophosphamide; Disease Progression; Disease-Free Survival; Female; Glomerular Filtration Rate; Humans; Hypertension; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Nephritis; Male; Methylprednisolone; Prednisone; Proteinuria; Remission Induction; Retrospective Studies; Risk Assessment; Risk Factors; South Africa; Survival Rate; Time Factors; Treatment Failure; Young Adult	2013
Long-term outcome in lupus nephritis. Annals of internal medicine, 2002, Sep-17, Volume: 137, Issue:6 Topics: Anti-Inflammatory Agents; Cyclophosphamide; Data Interpretation, Statistical; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lupus Nephritis; Methylprednisolone; Treatment Outcome	2002
Life-threatening extrarenal lupus in children despite improvement in serologic findings. Rheumatology international, 2003, Volume: 23, Issue:2 Topics: Adolescent; Anti-Inflammatory Agents; Child; Female; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Lupus Vasculitis, Central Nervous System; Methylprednisolone; Myocarditis; Treatment Outcome	2003
Treatment of pulmonary hemorrhage in childhood systemic lupus erythematosus with mycophenolate mofetil. Southern medical journal, 2003, Volume: 96, Issue:7 Topics: Adolescent; Combined Modality Therapy; Disease Progression; Drug Therapy, Combination; Hemorrhage; Humans; Hydroxychloroquine; Immunosuppressive Agents; Infusions, Intravenous; Lung Diseases; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methylprednisolone; Mycophenolic Acid; Plasmapheresis; Prednisone; Respiration, Artificial	2003
Refractory immune thrombocytopenia in systemic lupus erythematosus: response to mycophenolate mofetil. Lupus, 2003, Volume: 12, Issue:8 Topics: Adrenal Cortex Hormones; Adult; Antibodies, Antiphospholipid; Dose-Response Relationship, Drug; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Mycophenolic Acid; Platelet Count; Purpura, Thrombocytopenic, Idiopathic	2003
Clinical predictors of recovery and complications in the management of recent-onset renal failure in lupus nephritis: a Chinese experience. The Journal of rheumatology, 2004, Volume: 31, Issue:4 Topics: Adult; China; Cohort Studies; Cyclophosphamide; Female; Forecasting; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Methylprednisolone; Prednisone; Proportional Hazards Models; Recovery of Function; Renal Insufficiency; Retrospective Studies; Survival Rate; Treatment Outcome	2004
Retrospective analysis of the renal outcome of pediatric lupus nephritis. Clinical rheumatology, 2004, Volume: 23, Issue:4 Topics: Adolescent; Child; Cyclophosphamide; Disease-Free Survival; Female; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Function Tests; Lupus Nephritis; Male; Methylprednisolone; Pulse Therapy, Drug; Retrospective Studies; Survival Rate	2004
[Plasmapheresis in a case of necessary discontinuation of cyclophosphamide in the treatment of severe lupus nephritis]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2004, Volume: 17, Issue:98 Topics: Anti-Inflammatory Agents; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Methylprednisolone; Middle Aged; Plasmapheresis; Treatment Outcome	2004
Relapse of lupus nephritis more than 10 years after complete remission. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, Volume: 20, Issue:9 Topics: Adolescent; Adult; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Methylprednisolone; Mycophenolic Acid; Recurrence; Time Factors; Treatment Outcome	2005
Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children. Pediatric nephrology (Berlin, Germany), 2005, Volume: 20, Issue:10 Topics: Administration, Oral; Child; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Injections, Intravenous; Kidney; Lupus Nephritis; Male; Methylprednisolone; Prednisolone; Remission Induction; Ribonucleosides; Severity of Illness Index	2005
[Immune intervention therapy of lupus nephritis must be individualized and standardized]. Zhonghua yi xue za zhi, 2005, Apr-13, Volume: 85, Issue:14 Topics: Drug Administration Schedule; Female; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Nephritis; Male; Methylprednisolone	2005
Treatment of proliferative lupus nephritis: a changing landscape. Kidney international, 2006, Volume: 70, Issue:4 Topics: Anti-Inflammatory Agents; Azathioprine; Creatinine; Cyclophosphamide; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lupus Nephritis; Methylprednisolone; Mycophenolic Acid; Prednisolone; Randomized Controlled Trials as Topic	2006
Histologic deterioration and more flares: the case against azathioprine plus methylprednisolone in the treatment of proliferative lupus nephritis. Arthritis and rheumatism, 2007, Volume: 56, Issue:3 Topics: Anti-Inflammatory Agents; Azathioprine; Biopsy; Creatinine; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Kidney; Lupus Nephritis; Methylprednisolone; Prednisone; Treatment Outcome	2007
Predictive factors of clinical outcome in patients with diffuse proliferative lupus nephritis treated early by intravenous methylprednisolone pulse therapy. Renal failure, 2007, Volume: 29, Issue:1 Topics: Adult; Female; Glucocorticoids; Humans; Infusions, Intravenous; Kidney; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Prognosis; Pulse Therapy, Drug; Retrospective Studies	2007
Clinical characteristics of lupus myocarditis in Korea. Rheumatology international, 2008, Volume: 28, Issue:3 Topics: Adrenal Cortex Hormones; Adult; Cyclophosphamide; Death, Sudden, Cardiac; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Korea; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Myocarditis; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Young Adult	2008
Silica-associated systemic lupus erythematosus in an elderly man. Internal medicine (Tokyo, Japan), 2007, Volume: 46, Issue:22 Topics: Aged; Glucocorticoids; Humans; Lung; Lupus Nephritis; Male; Methylprednisolone; Prednisolone; Radiography; Silicon Dioxide; Silicosis	2007
Immunoadsorbent apheresis eliminates pathogenic IgG in childhood lupus nephritis. Pediatrics international : official journal of the Japan Pediatric Society, 2007, Volume: 49, Issue:6 Topics: Antibodies, Antinuclear; Blood Component Removal; Child; Female; Glucocorticoids; Humans; Immunoglobulin G; Immunosorbents; Immunosuppression Therapy; Kidney; Lupus Nephritis; Methylprednisolone	2007
Lupus nephritis in children. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2008, Volume: 18, Issue:1 Topics: Adolescent; Adrenal Cortex Hormones; Age Factors; Azathioprine; Biopsy; Child; Cyclophosphamide; Female; Glomerulonephritis; Glucocorticoids; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Methylprednisolone; Pakistan; Prospective Studies	2008
Evaluation of lupus nephritis during pregnancy by renal biopsy. American journal of nephrology, 1995, Volume: 15, Issue:3 Topics: Adult; Biopsy; Cyclophosphamide; Female; Follow-Up Studies; Humans; Kidney; Kidney Failure, Chronic; Lupus Nephritis; Methylprednisolone; Microscopy, Electron; Prednisone; Pregnancy; Pregnancy Complications; Puerperal Disorders; Time Factors	1995
[Effects of methylprednisolone pulse therapy on TNF alpha levels in chronic nephritis]. Zhonghua nei ke za zhi, 1994, Volume: 33, Issue:12 Topics: Adolescent; Adult; Child; Drug Administration Schedule; Female; Glomerulonephritis, Membranoproliferative; Humans; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Tumor Necrosis Factor-alpha	1994
Clinical significance of necrosis in lupus nephritis. Internal medicine (Tokyo, Japan), 1994, Volume: 33, Issue:8 Topics: Administration, Oral; Antibodies, Antinuclear; Biopsy; Complement System Proteins; Hematuria; Humans; Infusions, Intravenous; Kidney; Lupus Nephritis; Methylprednisolone; Necrosis; Prednisolone; Proteinuria; Radioimmunoassay	1994
Therapy of proliferative lupus glomerulonephritis: a prospective trial in The Netherlands. The Netherlands journal of medicine, 1994, Volume: 45, Issue:6 Topics: Azathioprine; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Humans; Lupus Nephritis; Methylprednisolone; Multicenter Studies as Topic; Prednisone; Prospective Studies; Randomized Controlled Trials as Topic	1994
Modulation of glomerular structure and function in murine lupus nephritis by methylprednisolone and cyclophosphamide. The Journal of laboratory and clinical medicine, 1994, Volume: 124, Issue:4 Topics: Animals; Base Sequence; Cyclophosphamide; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Interleukin-6; Kidney Glomerulus; Lupus Nephritis; Methylprednisolone; Mice; Mice, Mutant Strains; Molecular Sequence Data; Oligonucleotide Probes; Polymerase Chain Reaction; Transcription, Genetic; Tumor Necrosis Factor-alpha	1994
[Treatment of rapid progressive glomerulonephritis (RPGN) with pulse methylprednisolone (MP) and urokinase (UK): a renal rebiopsy study]. Zhonghua nei ke za zhi, 1993, Volume: 32, Issue:9 Topics: Adolescent; Adult; Biopsy, Needle; Drug Administration Schedule; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Glomerulonephritis; Humans; Kidney; Lupus Nephritis; Male; Methylprednisolone; Urokinase-Type Plasminogen Activator	1993
Long term efficacy of high-dose intravenous methylprednisolone pulses in active lupus nephritis. A 21-month prospective study. Scandinavian journal of rheumatology, 1994, Volume: 23, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Aged; Complement C3; Complement C4; Creatinine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Prednisone; Prospective Studies; Pulsatile Flow; Time Factors; Treatment Outcome	1994
Deterioration of renal function in a patient with lupus. Annals of the rheumatic diseases, 1994, Volume: 53, Issue:1 Topics: Adult; Biopsy; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone	1994
Gene expression of metalloproteinases and their inhibitor in renal tissue of New Zealand black/white F1 mice. Clinical science (London, England : 1979), 1993, Volume: 85, Issue:3 Topics: Animals; Blotting, Northern; Collagenases; Disease Models, Animal; Female; Gene Expression Regulation, Enzymologic; Glycoproteins; Hybridization, Genetic; Kidney; Lupus Nephritis; Matrix Metalloproteinase 9; Metalloendopeptidases; Methylprednisolone; Mice; Mice, Inbred Strains; RNA, Messenger; Tissue Inhibitor of Metalloproteinases	1993
High-dose 15-deoxyspergualin monotherapy surpasses methylprednisolone in its therapeutic effect on advanced lupus nephritis in New Zealand black/white F1 hybrid mice, and low-dose combination may be synergistic. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1993, Volume: 8, Issue:8 Topics: Animals; Drug Synergism; Drug Therapy, Combination; Female; Guanidines; Hybridization, Genetic; Lupus Nephritis; Methylprednisolone; Mice; Mice, Inbred NZB	1993
[Pulsed dose intravenous steroid treatment in the therapy of acute lupus nephritis with renal failure]. Polskie Archiwum Medycyny Wewnetrznej, 1993, Volume: 89, Issue:1 Topics: Adolescent; Adult; Creatinine; Female; Humans; Injections, Intravenous; Kidney Failure, Chronic; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Prednisolone; Remission Induction	1993
Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis. Laboratory investigation; a journal of technical methods and pathology, 1995, Volume: 73, Issue:6 Topics: Adult; Chemokine CCL2; Female; Humans; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; RNA, Messenger	1995
Transition of morphologic features in lupus nephritis: does steroid therapy accelerate glomerulosclerosis? Internal medicine (Tokyo, Japan), 1995, Volume: 34, Issue:10 Topics: Biopsy; Disease Progression; Follow-Up Studies; Glomerulonephritis; Humans; Kidney; Lupus Nephritis; Methylprednisolone; Microscopy, Electron; Microscopy, Fluorescence; Retrospective Studies	1995
Lupus nephritis in children: a longitudinal study of prognostic factors and therapy. Journal of the American Society of Nephrology : JASN, 1996, Volume: 7, Issue:6 Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Disease Progression; Drug Therapy, Combination; Female; Humans; Kidney Failure, Chronic; Longitudinal Studies; Lupus Nephritis; Male; Methylprednisolone; Prednisone; Prognosis; Survival Analysis; Treatment Outcome	1996
[Long-term renal prognosis in patients with lupus nephritis treated with pulse methylprednisolone]. Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 1996, Volume: 19, Issue:3 Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Kidney; Kidney Function Tests; Kidney Glomerulus; Lupus Nephritis; Methylprednisolone; Prognosis; Risk Factors; Sclerosis; Severity of Illness Index	1996
A pregnant woman with lupus Tulane Renal Biopsy Conference. The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society, 1997, Volume: 149, Issue:11 Topics: Adult; Anti-Inflammatory Agents; Biopsy, Needle; Female; Follow-Up Studies; Humans; Lupus Nephritis; Methylprednisolone; Pregnancy; Pregnancy Complications; Pregnancy Outcome	1997
Bindarit retards renal disease and prolongs survival in murine lupus autoimmune disease. Kidney international, 1998, Volume: 53, Issue:3 Topics: Animals; Antibodies, Antinuclear; Blood Urea Nitrogen; Chemokine CCL2; Female; Humans; Indazoles; Inflammation Mediators; Kidney; Lupus Nephritis; Methylprednisolone; Mice; Mice, Inbred NZB; Propionates; Proteinuria; Rats	1998
Treatment of membranous lupus nephritis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1998, Volume: 31, Issue:4 Topics: Adolescent; Adrenal Cortex Hormones; Adult; Chlorambucil; Drug Evaluation; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Lupus Nephritis; Methylprednisolone; Middle Aged; Nephrotic Syndrome; Proteinuria; Retrospective Studies; Time Factors; Treatment Outcome	1998
[Effects of methylprednisolone (MPS) on induction of apoptosis and expression of interleukin-1 beta-converting enzyme (ICE) in the kidneys of MRL-LPR/LPR mice]. Zhonghua nei ke za zhi, 1997, Volume: 36, Issue:2 Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Caspase 1; Gene Expression Regulation; Kidney; Lupus Nephritis; Methylprednisolone; Mice; Random Allocation; RNA, Messenger	1997
Combination of immunoadsorption therapy and high-dose methylprednisolone in patients with lupus nephritis; possible indications in patients with early stage. Journal of clinical & laboratory immunology, 1997, Volume: 49, Issue:2 Topics: Adolescent; Adult; Antibodies, Antinuclear; Autoimmune Diseases; Creatinine; Evaluation Studies as Topic; Female; Humans; Immunosorbent Techniques; Immunosuppressive Agents; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Nephrotic Syndrome; Plasmapheresis; Proteinuria; Serum Albumin	1997
[Management of lupus nephritis in Senegal]. Dakar medical, 1997, Volume: 42, Issue:2 Topics: Amenorrhea; Anti-Inflammatory Agents; Autoimmune Diseases; Cyclophosphamide; Female; Femur Head Necrosis; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Lupus Nephritis; Methylprednisolone; Middle Aged; Prednisone; Proteinuria; Senegal	1997
Concomitant lupus nephritis and bullous eruption in systemic lupus erythematosus. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14, Issue:7 Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Dapsone; Humans; Kidney; Lupus Nephritis; Male; Methylprednisolone; Microscopy, Electron; Middle Aged; Skin; Skin Diseases, Vesiculobullous	1999
Clinical and prognostic value of serial renal biopsies in lupus nephritis. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1999, Volume: 34, Issue:3 Topics: Adolescent; Adult; Azathioprine; Biopsy; Creatinine; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney; Kidney Function Tests; Lupus Nephritis; Male; Methylprednisolone; Prednisolone; Treatment Outcome	1999
[Results of treatment of lupus nephritis in children. Own experience]. Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2000, Volume: 8, Issue:46 Topics: Adolescent; Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Child; Child, Preschool; Cyclophosphamide; Female; Follow-Up Studies; Humans; Lupus Nephritis; Male; Methylprednisolone; Remission Induction; Retrospective Studies; Treatment Outcome	2000
Acute lupus peritonitis during treatment of lupus nephritis: successful treatment with methylprednisolone pulse therapy. Nephron, 2000, Volume: 86, Issue:4 Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Ascites; Female; Humans; Kidney Function Tests; Lupus Nephritis; Methylprednisolone; Peritonitis; Ultrasonography	2000
Severe arthralgia and myalgia due to high-dose methylprednisolone pulse therapy cured by potassium infusion in a patient with diffuse proliferative lupus nephritis. Nephron, 2001, Volume: 87, Issue:1 Topics: Adult; Anti-Inflammatory Agents; Arthralgia; Fibromyalgia; Humans; Lupus Nephritis; Male; Methylprednisolone; Potassium; Pulse Therapy, Drug	2001
Lupus nephritis in children: prognostic significance of clinicopathological findings. Nephron, 2001, Volume: 87, Issue:2 Topics: Adolescent; Anemia; Blood Pressure; Child; Child, Preschool; Creatinine; Cyclophosphamide; Female; Humans; Hypertension; Lupus Nephritis; Male; Methylprednisolone; Nephrotic Syndrome; Prednisone; Prognosis; Proteinuria; Turkey	2001
Mannitol treatment in central nervous system lupus. Clinical rheumatology, 2001, Volume: 20, Issue:2 Topics: Administration, Oral; Allopurinol; Brain Ischemia; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Free Radical Scavengers; Humans; Injections, Intravenous; Lupus Nephritis; Lupus Vasculitis, Central Nervous System; Magnetic Resonance Imaging; Mannitol; Methylprednisolone; Prednisolone; Treatment Outcome	2001
The treatment of lupus nephritis: revisiting Galen. Annals of internal medicine, 2001, Aug-21, Volume: 135, Issue:4 Topics: Anti-Inflammatory Agents; Cyclophosphamide; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Infusions, Intravenous; Lupus Nephritis; Methylprednisolone; Remission Induction	2001
[Lupus nephritis in the middle of the 20th century and in the beginning of 21st century]. Terapevticheskii arkhiv, 2001, Volume: 73, Issue:6 Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Lupus Nephritis; Male; Meta-Analysis as Topic; Methylprednisolone; Plasmapheresis; Prognosis; Time Factors; Virus Diseases	2001
Summaries for patients. Kidney disease in patients with lupus who are treated with potent drugs that suppress the immune system. Annals of internal medicine, 2001, Aug-21, Volume: 135, Issue:4 Topics: Anti-Inflammatory Agents; Cyclophosphamide; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Lupus Nephritis; Methylprednisolone	2001
Severe pulmonary hemorrhage as the initial manifestation in systemic lupus erythematosus with active nephritis. Lupus, 2001, Volume: 10, Issue:12 Topics: Adolescent; Anti-Inflammatory Agents; Hemoptysis; Humans; Lupus Nephritis; Male; Methylprednisolone; Pulse Therapy, Drug; Radiography	2001
[Appraisal of renal failure reversing therapies in lupus nephritis]. Zhonghua nei ke za zhi, 2001, Volume: 40, Issue:2 Topics: Administration, Oral; Cohort Studies; Cyclophosphamide; Cyclosporine; Dexamethasone; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Injections, Intravenous; Lupus Nephritis; Male; Methylprednisolone; Prednisone; Proportional Hazards Models; Recovery of Function; Renal Insufficiency; Retrospective Studies	2001
Glucocorticoid ameliorates altered gene expression of extracellular matrix components in kidneys of New Zealand black/white F1 mice. Clinical science (London, England : 1979), 1992, Volume: 83, Issue:6 Topics: Animals; Collagen; Extracellular Matrix Proteins; Female; Gene Expression; Kidney; Kidney Cortex; Lupus Nephritis; Methylprednisolone; Mice; Mice, Inbred NZB; Proteinuria; RNA, Messenger; Time Factors	1992
Treatment of the acute phase of lupus nephritis with 6-methylprednisolone pulses. Contributions to nephrology, 1992, Volume: 99 Topics: Acute Disease; Adolescent; Adult; Antibodies, Antinuclear; Complement C3; Complement C4; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Lupus Nephritis; Male; Methylprednisolone; Middle Aged	1992
Lupus nephritis associated with bacterial panperitonitis and lung alveolar hemorrhage. Internal medicine (Tokyo, Japan), 1992, Volume: 31, Issue:5 Topics: Adult; Female; Hemorrhage; Humans; Lung Diseases; Lupus Nephritis; Methylprednisolone; Peritonitis; Pulmonary Alveoli; Staphylococcal Infections	1992
Detection of DNA-bound immunoglobulins in patients with lupus nephritis, using monoclonal anti-DNA antibody. Clinical and experimental immunology, 1991, Volume: 85, Issue:2 Topics: Antibodies, Antinuclear; Antibodies, Monoclonal; Antigen-Antibody Complex; Autoantibodies; Complement C1q; DNA; Humans; Kidney Glomerulus; Lupus Nephritis; Methylprednisolone	1991
Pathogenesis and treatment of lupus nephritis. Nihon Jinzo Gakkai shi, 1991, Volume: 33, Issue:5 Topics: Animals; Autoimmunity; Azathioprine; Cyclosporins; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Methylprednisolone; Plasma Exchange; Prednisolone; Pregnancy; Pregnancy Complications	1991
Effects of the methylprednisolone pulse therapy on renal function. American journal of nephrology, 1991, Volume: 11, Issue:1 Topics: Acute Kidney Injury; Adult; Aged; Female; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Nephrotic Syndrome	1991
[The use of ultrahigh doses of corticosteroids in treating the most severe variants of lupus nephritis]. Terapevticheskii arkhiv, 1990, Volume: 62, Issue:6 Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Azathioprine; Chronic Disease; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Nephrotic Syndrome; Prednisolone; Remission Induction	1990
[Clinical symptoms and therapy of lupus nephritis]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1990, Oct-10, Volume: 79, Issue:10 Topics: Adult; Antigen-Antibody Complex; Blood Coagulation; Female; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Prognosis; World Health Organization	1990
[Effect of methylprednisolone pulse therapy in patients with lupus nephritis assessed by WHO morphologic classification]. Nihon Jinzo Gakkai shi, 1990, Volume: 32, Issue:7 Topics: Administration, Oral; Drug Administration Schedule; Drug Evaluation; Humans; Lupus Nephritis; Methylprednisolone; Retrospective Studies	1990
Methylprednisolone in systemic lupus erythematosus. Singapore medical journal, 1990, Volume: 31, Issue:1 Topics: Adolescent; Adult; Child; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Methylprednisolone; Middle Aged; Retrospective Studies	1990
[Treatment of chronic glomerulonephritis with high doses of intravenous immunoglobulin]. Vutreshni bolesti, 1990, Volume: 29, Issue:1 Topics: Azathioprine; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Glomerulonephritis; Heparin; Humans; Immunoglobulin G; Infusions, Intravenous; Lupus Nephritis; Methylprednisolone; Time Factors	1990
Improvement of histological and immunological change in steroid and immunosuppressive drug-resistant lupus nephritis by high-dose intravenous gamma globulin. Nephron, 1989, Volume: 53, Issue:4 Topics: Antigen-Antibody Complex; Biopsy; Child; Complement C3; Complement C4; Cyclophosphamide; Drug Resistance; Female; Fluorescent Antibody Technique; gamma-Globulins; Humans; Injections, Intravenous; Kidney; Lupus Nephritis; Male; Methylprednisolone	1989
[Recovery of kidney function in a female patient with severe lupus nephropathy]. Anales de medicina interna (Madrid, Spain : 1984), 1989, Volume: 6, Issue:4 Topics: Adult; Azathioprine; Combined Modality Therapy; Female; Humans; Kidney Failure, Chronic; Lupus Nephritis; Methylprednisolone; Plasmapheresis; Renal Dialysis	1989
Thrombotic microangiopathy in lupus nephritis. Advances in experimental medicine and biology, 1989, Volume: 252 Topics: Acute Kidney Injury; Adult; Antibodies, Antinuclear; Anticoagulants; Female; Humans; Lupus Nephritis; Male; Methylprednisolone; Microcirculation; Renal Dialysis; Thrombosis	1989
Atrial fibrillation following methylprednisolone pulse therapy. Pediatric nephrology (Berlin, Germany), 1988, Volume: 2, Issue:1 Topics: Adolescent; Atrial Fibrillation; Child; Female; Humans; Lupus Nephritis; Male; Methylprednisolone; Nephrotic Syndrome	1988
[Corticosteroids administered in bolus in lupus nephropathy]. Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna, 1986, Volume: 1, Issue:1 Topics: Adrenal Cortex Hormones; Adult; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Lupus Nephritis; Methylprednisolone; Prednisone	1986
Discontinuation of therapy in diffuse proliferative lupus nephritis. The American journal of medicine, 1988, Volume: 85, Issue:2 Topics: Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Follow-Up Studies; Humans; Lupus Nephritis; Methylprednisolone; Prednisone	1988
Acute impairment of renal function in systemic lupus erythematosus. Advances in experimental medicine and biology, 1987, Volume: 212 Topics: Acute Kidney Injury; Adolescent; Adult; Female; Humans; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Methylprednisolone; Middle Aged; Prognosis	1987
Pulsed methylprednisolone therapy compared to high dose prednisone in systemic lupus erythematosus nephritis. European journal of pediatrics, 1986, Volume: 145, Issue:5 Topics: Adolescent; Adult; Blood Pressure; Child; Complement C3; Complement C4; Creatinine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lupus Nephritis; Male; Methylprednisolone; Prednisone	1986